Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China · Delayed Price · Currency is CNY 68.28
-0.95 (-1.37%)
Feb 13, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 5.35 billion as of February 13, 2026. Its market cap has increased by 1.19% in one year.
Market Cap
5.35B
Enterprise Value
2.90B
Revenue
881.63M
Ranking
n/a
PE Ratio
18.36
Stock Price
68.28
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 5.35B, a decrease of -42.97%. That is a compound annual growth rate of -10.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.35B | 6.87% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
| Mar 25, 2021 | 9.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allmed Medical Products Co.,Ltd | 6.85B |
| Blue Sail Medical | 5.99B |
| Aidite (Qinhuangdao) Technology | 5.88B |
| Qingdao NovelBeam Technology | 5.78B |
| Zhonghong Pulin Medical Products | 5.73B |
| SWS Hemodialysis Care | 5.47B |
| Jiangxi Sanxin Medtec | 4.87B |
| Chimin Health Management | 4.70B |